Method for predicting sorption of small drug molecules onto polylactide

Journal of Biomedical Materials Research - Part A

Volumn 88, Issue 1, 2009, Pages 255-263

  Karst, David ^a   Yang, Yiqi ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Adsorption; Drug controlled release; Functional groups; Molecular modeling; Polylactide

Indexed keywords

ADSORBATES; ADSORPTION; EQUILIBRIUM CONSTANTS; EXPERIMENTS; FLOW INTERACTIONS; FORECASTING; FUNCTIONAL GROUPS; FUNCTIONAL POLYMERS; MOLECULAR MODELING; POLYMERS; SORPTION; SURFACE STRUCTURE;

CONTROLLED RELEASES; DRUG MOLECULES; DRUG-CONTROLLED RELEASE; EXPERIMENTAL DATUMS; GROUP CONTRIBUTIONS; INTERACTION ENERGIES; POLYLACTIDE; SORPTION DATUMS; SORPTION EQUILIBRIUMS;

DRUG INTERACTIONS;

FUNCTIONAL GROUP; POLYLACTIDE;

ADSORPTION; ARTICLE; CONTROLLED DRUG RELEASE; ENERGY TRANSFER; EQUILIBRIUM CONSTANT; METHODOLOGY; MOLECULAR MODEL;

ADSORPTION; DELAYED-ACTION PREPARATIONS; METHODS; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS; POLYESTERS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57449093401     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31882     Document Type: Article

References (52)

1. Paul M, Laatiris A, Fessi H, Dufeu B, Durand R, Deniau M, Astier A. Pentamidine-loaded poly(D,L-lactide) nanoparticles: Adsorption and drug release. Drug Develop Res 1998;43:98-104.
2. Ueda M, Iwara A, Kreuter J. Influence of the preparation methods on the drug release behavior of loperamide-loaded nanoparticles. J Microencapsul 1998;15:361-372.
3. Huda S, Reddy N, Karst D, Xu W, Yang W, Yang Y. Nontraditional biofibers for a new textile industry. J Biobased Mater Bioenergy 2007;1:177-190.
4. Patel HJ, Su S, Patterson C, Nguyen KT. A combined strategy to reduce restenosis for vascular tissue engineering applications. Biotechnol Progr 2006;22:38-44.
5. Lunt J, Bone J. Properties and dyeabiltiy of fibers and fabrics produced from polylactide (PLA) polymers. AATCC Rev 2001;1:20-23.
6. Reddy N, Nama N, Yang Y. Polylactic acid/polypropylene polyblend fibers for better resistance to degradation. Polym Degrad Stab, doi:10.1016/j. polymdegradstab. 2007.09.005.
7. Sugiura K, Ogawa S, Tabata I, Hori T. Impregnation of tranilast to the poly(lactic acid) fiber with supercritical carbon dioxide and the release behavior of tranilast. Sen'i Gakkaishi 2005;61:159-165.
8. Blackburn RS, Zhao X, Farrington DW, Johnson L. Effect of D-isomer concentration on the coloration properties of poly(lactic acid). Dyes Pigments 2005;70:251-258.
9. Karst D, Yang Y. Using the solubility parameter to explain disperse dye sorption on polylactide. J Appl Polym Sci 2005;96:416-422.
10. Karst D, Nama D, Yang Y. Effect of disperse dye structure on dye sorption onto PLA fiber. J Colloid Interface Sci 2007;310:106-111.
11. Phillips D, Suesat J, Wilding M, Farrington D, Sandukas S, Bone J, Dervan S. Effect of heat setting on dimensional stability and dyeing properties of poly(lactic acid) fibres. Color Technol 2003;119:128-133.
12. Scheyer LE, Chiweshe A. Application and performance of disperse dyes on polylactic acid (PLA) fabric. AATCC Rev 2001;1:44-48.
13. Yang Y, Huda S. Dyeing conditions and their effects on mechanical properties of polylactide fabric. AATCC Rev 2003;3:56-61.
14. Yang Y, Huda S. Comparison of disperse dye exhaustion, color yield, and colorfastness between polylactide and poly(ethylene terephthalate). J Appl Polym Sci 2003;90:3285-3290.
15. Da Silva Perez D, Reinaldo R, Morais LC, Machado AEH, Mazeau K. Theoretical and experimental studies on the adsorption of aromatic compounds onto cellulose. Langmuir 2004;20:3151-3158.
16. Agrawal SK, Sanabria-DeLong N, Coburn JM, Tew GN, Bhatia SR. Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers. J Control Release 2006;112:64-71.
17. Ahuja A, Ali J, Rahman S. Biodegradable periodontal intra-pocket device containing metronidazole and amoxycillin: Formulation and characterization. Pharmazie 2006;61:25-29.
18. Billon A, Chabaud L, Gouyette A, Bouler JM, Merle C. Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release. J Microencapsul 2005;22:841-852.
19. Bishara A, Kricheldorf HR, Domb AJ. Stereocomplexes of triblock poly(lactide-PEG2000-lactide) as carrier of drugs. Stereocomplexes of triblock poly(lactide-PEG2000-lactide) as carrier of drugs. Macromol Symp 2005;225:17-30.
20. Chen X, Ooi CP, Lye WS, Lim TH. Sustained release of ganciclovir from poly(lactide-co-glycolide) microspheres. J Microencapsul 2005;22:621-631.
21. Duvvuri S, Gaurav Janoria K, Mitra AK. Effect of polymer blending on the release of ganciclovir from PLGA microspheres. Pharm Res 2006;23:215-223.
22. Freitas MN, Marchetti JM. Nimesulide PLA microspheres as a potential sustained release system for the treatment of inflammatory diseases. Int J Pharm 2005;295:201-211.
23. Hickey AJ, Tian Y, Parasrampuria D, Kanke M. Biliary elimination of bromsulfthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration. Biopharm Drug Dispos 1993;14:181-186.
24. Huang J, Liu H, Gu W, Yan Z, Xu Z, Yang Y, Zhu X, Li Y. A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease. Biomaterials 2006;27:937-946.
25. Ishihara K, Konno T, Kurita K, Iwasaki Y, Nakabayashi N. Preparation of blood-compatible nanoparticles bearing phosphorylcholine group. ACS Symp Ser 2000;752:414-427.
26. Lamprecht A, Rodero Torres H, Schafer U, Lehr CM. Biodegradable microparticles as a two-drug controlled release formulation: A potential treatment of inflammatory bowel disease. J Control Release 2000;69:445-454.
27. 2-based microencapsulation. Langmuir 2005;21:379-385.
28. Lo C, Lin K, Hsiue G. Preparation and characterization of intelligent core-shell nanoparticles based on poly(D,L-lactide)-g-poly(N- isopropyl acrylamide-co-methacrylic acid). J Control Release 2005;104:477-488.
29. Luan X, Bodmeier R. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. J Control Release 2006;110:266-272.
30. Maekinen TJ, Veiranto M, Lankinen P, Moritz N, Jalava J, Toermaelae P, Aro HT. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 2005;56:1063-1068.
31. Moll F, Koeller G. Biodegradable tablets having a matrix of low-molecular-weight poly(L-lactic acid) and poly(DL-lactic acid). Arch Pharmacol 1990;323:887-888.
32. Onishi H, Takahashi M, Machida Y. PLGA implant tablet of ketoprofen: Comparison of in vitro and in vivo releases. Biol Pharm Bull 2005;28:2011-2015.
33. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984;19:107-127.
34. Park J, Allen MG, Prausnitz MR. Polymer microneedles for controlled-release drug delivery. Pharm Res 2006;23:1008-1019.
35. Puebla P, Pastoriza P, Barcia E, Fernandez-Carballido A. PEG-derivative effectively modifies the characteristics of indomethacin-PLGA microspheres destined to intra-articular administration. J Microencapsul 2005;22:793-808.
36. Rouzes C, Leonard M, Durand A, Dellacherie E. Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres. Colloid Surf B 2003;32:125-135.
37. Song Y, Liu L, Weng X, Zhuo R. Acid-initiated polymerization of ε-caprolactone under microwave irradiation and its application in the preparation of drug controlled release system. J Biomater Sci Polym E 2003;14:241-253.
38. Tom JW, Lim GB, Debenedetti PG, Prud'homme RK. Applications of supercritical fluids in the controlled release of drugs. ACS Symp Ser 1993;514:238-257.
39. Xie J, Marijnissen JCM, Wang C. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. Biomaterials 2006;27:3321-3332.
40. Yoshioka S, Kishida A, Izumikawa S, Aso Y, Takeda Y. Base-induced polymer hydrolysis in poly(β-hydroxybutyrate/β-hydroxyvalerate) matrixes. J Control Release 1991;16:341-347.
41. Zhou T, Foster RE, Lewis H, Schwendeman SP.A multi-drug controlled-release implant for intraocular treatment of proliferative vitreoretinopathy. In: Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials; Stockholm: Controlled Release Society; 1997. p 625-626.
42. Zhu W, Masaki T, Bae YH, Rathi R, Cheung AK, Kern SE. Development of a sustained-release system for perivascular delivery of dipyridamole. J Biomed Mater Res B 2006;77:135-143.
43. Accelrys Inc. MS Modeling 3.0. San Diego: Accelrys; 2003.
44. Karst DT, Yang Y, Tanaka G. An explanation of increased hydrolysis of the β-(1,4)-glycosidic linkages of grafted cellulose using molecular modeling. Polymer 2006;47:6464-6471.
45. Karst D, Yang Y. Effect of structure of large aromatic molecules grafted onto cellulose on hydrolysis of the glycosidic linkages. Macromol Chem Phys 2007;208:784-791.
46. Karst D, Yang Y. Molecular modeling study of the resistance of PLA to hydrolysis based on the blending of PLLA and PDLA. Polymer 2006;47:4845-4850.
47. Karst, D, Yang, Y. Effect of arrangement of L-lactide and D-lactide in poly(L-lactide-co-D-lactide) on its resistance to hydrolysis studied by molecular modeling. Macromol Chem Phys, doi:10.1002/macp. 200700283.
48. Sun H. Force field for computation of conformational energies, structures, and vibrational frequencies of aromatic polyesters. J Comput Chem 1994;15:752-768.
49. Sun H, Mumby SJ, Maple JR, Hagler AT. An ab initio CFF93 all-atom force field for polycarbonates. J Am Chem Soc 1994;116:2978-2987.
50. Sun H. Ab initio calculations and force field development for computer simulation of polysilanes. Macromolecules 1995;28:701-712.
51. Cramer CJ. Essentials of Computational Chemistry: Theories and Models. New York: Wiley; 2002. p 46, 82-84.
52. Louise-May S, Auffinger P, Westhof E. Calculations of nucleic acid conformations. Curr Opin Struct Biol 1996;6:289-298.